CALAN Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Calan, and what generic alternatives are available?
Calan is a drug marketed by Gd Searle Llc and Pfizer and is included in three NDAs.
The generic ingredient in CALAN is verapamil hydrochloride. There are seventeen drug master file entries for this compound. Forty-four suppliers are listed for this compound. Additional details are available on the verapamil hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Calan
A generic version of CALAN was approved as verapamil hydrochloride by EXELA PHARMA on March 30th, 1984.
Summary for CALAN
| US Patents: | 0 |
| Applicants: | 2 |
| NDAs: | 3 |
| Raw Ingredient (Bulk) Api Vendors: | 78 |
| Patent Applications: | 4,097 |
| Formulation / Manufacturing: | see details |
| Drug Prices: | Drug price information for CALAN |
| DailyMed Link: | CALAN at DailyMed |
Anatomical Therapeutic Chemical (ATC) Classes for CALAN
US Patents and Regulatory Information for CALAN
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gd Searle Llc | CALAN | verapamil hydrochloride | INJECTABLE;INJECTION | 019038-001 | Mar 30, 1984 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| Pfizer | CALAN SR | verapamil hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 019152-002 | Dec 15, 1989 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| Pfizer | CALAN | verapamil hydrochloride | TABLET;ORAL | 018817-002 | Sep 10, 1984 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| Pfizer | CALAN SR | verapamil hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 019152-001 | Dec 16, 1986 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| Pfizer | CALAN | verapamil hydrochloride | TABLET;ORAL | 018817-003 | Feb 23, 1988 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| Pfizer | CALAN | verapamil hydrochloride | TABLET;ORAL | 018817-001 | Sep 10, 1984 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| Pfizer | CALAN SR | verapamil hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 019152-003 | Mar 6, 1991 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
